STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

IRMD Rule 144 Notice: Trust Plans Sale of 100K Shares on 09/17/2025

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filed for IRADIMED CORP (IRMD) reports a proposed sale of 100,000 shares of common stock through Roth Capital Partners on 09/17/2025 with an aggregate market value of $7,076,000. The filing identifies the securities as held by the Phillip Susi 2008 Dynasty Trust, acquired on 01/01/1992, and indicates 2,362,500 shares were acquired by that trust on that date. The total shares outstanding reported in the filing are 12,720,002. The filer certifies there are no undisclosed material adverse facts known to the seller and states there were no sales in the past three months by the selling person.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: An authorized Form 144 notice records a planned sale of 100,000 IRMD shares by a trust; size is below typical materiality thresholds.

The filing documents a Rule 144 notice for sale through Roth Capital Partners of 100,000 common shares valued at $7,076,000 based on the filers stated market value. The securities are held by the Phillip Susi 2008 Dynasty Trust and were originally acquired on 01/01/1992. With 12,720,002 shares outstanding, the proposed sale represents approximately 0.79% of outstanding shares, which is unlikely to be material to company capitalization on its own. The filer also affirms no undisclosed material adverse information and reports no sales in the prior three months.

TL;DR: Routine insider/trust sale notice filed; disclosure appears complete for a Rule 144 transaction.

The document fulfills Rule 144 disclosure elements: identity of selling account, acquisition history, broker details, number of shares to be sold, approximate sale date, and a representation about material non-public information. The statement that no material adverse information is known is standard. There is no indication of accelerated selling or multiple recent disposals, as the form reports nothing to report for prior three-month sales.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the IRMD Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 100,000 shares of common stock via Roth Capital Partners on 09/17/2025 with an aggregate market value of $7,076,000.

Who is the selling holder in the IRMD Form 144?

The securities are reported as held by the Phillip Susi 2008 Dynasty Trust, acquired on 01/01/1992.

How large is the proposed sale relative to IRMD's outstanding shares?

The filing reports 12,720,002 shares outstanding; the proposed sale of 100,000 shares represents about 0.79% of outstanding shares.

Did the Form 144 report any sales in the prior three months?

The filing states "Nothing to Report" for securities sold during the past three months by the selling person.

What broker is handling the sale in the Form 144?

The broker listed is Roth Capital Partners, LLC at the Newport Beach, CA address provided.
Iradimed Corp

NASDAQ:IRMD

IRMD Rankings

IRMD Latest News

IRMD Latest SEC Filings

IRMD Stock Data

1.17B
8.05M
36.81%
59.44%
1.19%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ORLANDO